Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $19.34B.
ENTERPRISE VALUE (EV)
$19.34B
Solventum Corporation
Market Cap
$15.18B
Enterprise Value (EV)
$19.34B
Market Cap
$13.15B
Enterprise Value (EV)
$15.99B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Solventum Corporation (SOLV) | $15.18B | $19.34B |
| Exelixis, Inc. (EXEL)vs › | $14.44B | $14.32B |
| Medpace Holdings, Inc. (MEDP)vs › | $16.28B | $15.89B |
| Revvity, Inc. (RVTY)vs › | $13.49B | $15.81B |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.15B | $15.99B |
| Penumbra, Inc. (PEN)vs › | $12.52B | $12.52B |
| Baxter International Inc. (BAX)vs › | $12.50B | $20.02B |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.88B | $24.95B |
| Encompass Health Corporation (EHC)vs › | $12.01B | $14.74B |
| DaVita Inc. (DVA)vs › | $11.64B | $21.75B |
Market Cap
$15.18B
Total Debt
$5.04B
Cash
$878.00M
Enterprise Value
$19.34B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
